Infectious disease Archives

poland obama selvita epibiome microbiome ardigen

News and Trends 18 May 2016

Polish Bioinformatics company backs US movement into Microbiome Research

In Kraków, the Bioinformatics company Ardigen has now partnered up with a US based Microbiome startup, EpiBiome, which is looking for the answer to antibiotic resistance. This is another example of cross-Atlantic collaboration in the Microbiome world, just as President Obama pledges €105M ($121M) to the up and coming field of therapeutics. It’s a growing area of research, and as […]

May 18, 2016 - 2 minutesmins - By Philip Hemme

News and Trends 9 May 2016

Update: Cold Sore Season is Here! AiCuris might have a Herpes Cure

Update (09/05/2017): AiCuris has started a Phase II trial, PRIOH-1, with the oral version of its herpes cure pritelivir. Update (17/01/2017): The company has presented results from its first Phase II trial with pritelivir. The drug candidate proved to work better than the antiviral drug valacyclovir, currently the standard of care. Update (01/12/2017): AiCuris announced […]

May 9, 2016 - 2 minutesmins - By Evelyn Warner

News and Trends 7 May 2016

BioArt: Vibrant Paper Vaccines, Vitamins and Controversial Farming

Zim & Zou are a French duo making colourful 3D models. Their vibrant art raises awareness of the food industry, healthy eating and children’s vaccination. Zim & Zou is the graphic design studio of Thibaut Zimmerman and Lucie Thomas, based in Nancy (France). After studying design, the two 28-year olds moved away from digital work to focus on tangible installations […]

May 7, 2016 - 3 minutesmins - By Denise Neves Gameiro

epistem hepatitis hcv genedrive genotype

News and Trends 3 May 2016

Handheld Genetic Test proves itself for Hep-C with 100% Accuracy

Epistem’s molecular diagnostic (Genedrive) has achieved 100% accuracy in detecting a genotype relevant to Hepatitis – an important proof of concept for this field device. Located in Manchester (UK), Epistem has a market cap of €130,000 and 29 employees. One of its research areas is molecular diagnostics, under which it developed Genedrive. This device can make […]

May 3, 2016 - 3 minutesmins - By Denise Neves Gameiro

ablynx llama antigody nanobody rsv infant

News and Trends 3 May 2016

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

Ablynx has gotten positive results for its candidate (ALX-0171) in Phase I/IIa trial for infants infected with a life-threatening virus – respiratory syncytial virus (RSV). Located near Ghent (Belgium), Ablynx is making advances in its Nanobody platform, based on the shorter monoclonal antibodies of llamas. Due to their small size, these Nanobodies can be used in a […]

May 3, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 27 Apr 2016

Interviewing the CEO who uses Probiotics as Needle-free Vaccines

This is my first interview from BioTrinity 2016 in London. I met with Tom Johnston, CEO of Mucosis, to learn more about the needle-free vaccine platform he is developing. Mucosis is a biotechnology company based in Gröningen, Netherlands (a city we covered here for its medtech innovation). It was founded in 2007 and has raised over €20M so […]

April 27, 2016 - 1 minutemin - By Philip Hemme

Katharine dowson bioart science gallery hiv brain malformation glass

News and Trends 23 Apr 2016

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

Represented by the GV Art Gallery in London, Katharine Dowson is a glass sculptor who is well established in the BioArt community as an Anatomical and medicine specialist. Katharine studied at the Royal College of Art and Camberwell in London, with a focus spanning to include the anatomical form (particularly the Nervous system) to infectious diseases and developmental research into a […]

April 23, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 21 Apr 2016

New CRISPR Tool can cut RNA too: Gene Editing just got even Easier!

The research team led by Emannuelle Charpentier, co-discoverer of the CRISPR/Cas9 system, has found that a new CRISPR system can also cleave RNA. Amazingly simple! The discovery of the CRISPR/Cas9 system revolutionised Biotechnology, unlocking a kind of ‘Golden age’ for gene editing – with a wide-reaching impact from therapeutics to SynBio. So, it’s no wonder that […]

April 21, 2016 - 3 minutesmins - By Denise Neves Gameiro

Vibiosphen biotech infectious disease pierre fabre

News and Trends 15 Apr 2016

Pierre Fabre partners for Open Innovation in Infectious Disease

Pierre Fabre has a new partnership for its Open Innovation programme based on an extensive plant library. It will now count with VibioSphen to develop new phyto-chemicals to fight infectious diseases. Pierre Fabre is the 3rd largest Pharma in France, employing over 10,000 people and generating revenues of over €2Bn. Lately, this mid-sized company made efforts […]

April 15, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 13 Apr 2016

A New Cellular ‘Back Door’ has been found to fight Malaria

Paris & Strasbourg (France) researchers have discovered an ‘Achilles Heel’ for malaria: A specific molecule the parasite needs from the host. Could this spawn a new generation of Parasitic disease drugs? Malaria is a parasitic disease that was responsible for over 400,000 deaths worldwide just in 2015, according to the WHO – especially in sub-Saharan Africa. However, the current […]

April 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

humabs influenza antibody infectious cellclone medimmune

News and Trends 24 Mar 2016

Novel Antibody for Influenza gets FDA Fast-Track Approval

Humabs (Switzerland) has gotten some serious recognition for its antibody platform, as its candidates for Influenza have received FDA fast-track designation. A biologic therapy for Influenza A has been granted Fast Track Designation by the FDA, a ‘programme to accelerate the treatment commercialisation. The therapy is based on an antibody (MEDI8852) that was initially developed by […]

March 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

hiv virus vaccine la provence retroviral biosahntech anrs

News and Trends 23 Mar 2016

No, this French Startup didn’t Discover the Cure for HIV…

This is the story of a French doctor and his start-ups which have been trying to develop a cure for HIV for the last 10 years. The problem resides in exaggerating, not publishing data…and then repeating this process again and again. Last week, the professor Erwann Loret and his start-up Biosantech did a press conference to announce new “breakthrough” […]

March 23, 2016 - 3 minutesmins - By Philip Hemme

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Infectious disease

Polish Bioinformatics company backs US movement into Microbiome Research

Update: Cold Sore Season is Here! AiCuris might have a Herpes Cure

BioArt: Vibrant Paper Vaccines, Vitamins and Controversial Farming

Handheld Genetic Test proves itself for Hep-C with 100% Accuracy

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

Interviewing the CEO who uses Probiotics as Needle-free Vaccines

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

New CRISPR Tool can cut RNA too: Gene Editing just got even Easier!

Pierre Fabre partners for Open Innovation in Infectious Disease

A New Cellular ‘Back Door’ has been found to fight Malaria

Novel Antibody for Influenza gets FDA Fast-Track Approval

No, this French Startup didn’t Discover the Cure for HIV…

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!